SI Shoulder Innovations, Inc.

NYSE
$18.35

Shoulder Innovations, Inc. (SI) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with SI's own trailing one-year pace, with 15% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
3
7 transactions
Insiders selling
3
17 transactions
Purchases
$214.9K
14,400 shares
Sales
$5.5M
247,243 shares
Net activity
-$5.3M
purchases less sales

How much of that selling was preplanned? 15% planned / 85% discretionary

10b5-1 plan sales $839.1K 6 transactions · 42,500 shares
Discretionary sales $4.6M 11 transactions · 204,743 shares

Largest single sale: $2.3M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: March 13, 2026 , by Points Jeffrey S. .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Ball Robert Joseph CEO & Executive Chairman Sell 10,175 $18.45 $187.7K 380,824 −2.6% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 1,196 $22.60 $27.0K 2,185,914 −0.1% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 681 $22.62 $15.4K 2,187,110 −0% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 20,516 $22.61 $463.9K 2,187,791 −0.9% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 3,900 $22.60 $88.1K 2,208,307 −0.2% of holding
Ahearn Matthew Fraser 2 fills Chief Operating Officer Sell 10b5-1 14,186 $20.99 $297.7K 245,776 −5.5% of holding
Ahearn Matthew Fraser Chief Operating Officer Sell 10b5-1 8,314 $20.10 $167.1K 258,362 −3.1% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 2,095 $22.60 $47.3K 2,212,207 −0.1% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 7,338 $22.64 $166.1K 2,214,302 −0.3% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 99,812 $22.77 $2.3M 2,221,640 −4.3% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 10,751 $22.71 $244.2K 2,321,452 −0.5% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 20,034 $22.73 $455.4K 2,332,203 −0.9% of holding
Gilde Healthcare Holding B.V. 10% Owner Sell 28,245 $23.36 $659.8K 2,352,237 −1.2% of holding
Ahearn Matthew Fraser 2 fills Chief Operating Officer Sell 10b5-1 4,144 $18.84 $78.1K 271,676 −1.5% of holding
Ahearn Matthew Fraser Chief Operating Officer Sell 10b5-1 15,856 $18.68 $296.2K 273,320 −5.5% of holding
Ball Robert Joseph CEO & Executive Chairman Buy 2,200 $15.18 $33.4K 278,866
Points Jeffrey S. Chief Financial Officer Buy 2,000 $15.00 $30.0K 70,785
Buchholz Richard Director Buy 1,000 $14.84 $14.8K 13,666
Ball Robert Joseph CEO & Executive Chairman Buy 3,900 $14.89 $58.1K 118,457
Points Jeffrey S. Chief Financial Officer Buy 1,005 $14.98 $15.1K 54,445
Ball Robert Joseph CEO & Executive Chairman Buy 3,300 $14.83 $48.9K 114,557
Points Jeffrey S. Chief Financial Officer Buy 995 $14.65 $14.6K 53,440

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.